Inogen | INGN - DEBITO





DEBITO Cambiamento Data
Abbott USD 12.94B 496M 2025-09
Accuray USD 170.24M 4.52M 2024-09
AngioDynamics USD 6.3M 6.3M 2025-02
Artivion USD 317.78M 619K 2024-12
AtriCure USD 76.73M 521K 2025-09
Baxter International USD 9.71B 13M 2025-09
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Boston Scientific USD 12.05B 19M 2025-09
Chart Industries USD 3.65B 17.9M 2025-09
Cooper Companies USD 2.51B 27M 2025-09
Dexcom USD 1.24B 1.21B 2025-12
Edwards Lifesciences USD 700.3M 2.3M 2025-09
Globus Medical USD 119.34M 1.76M 2025-09
Inogen USD 0 0 2022-06
Insulet USD 1.01B 384.9M 2025-09
Masimo USD 586.2M 56M 2025-09
Medtronic USD 28.07B 1.03B 2025-12
Orthofix International USD 137.23M 338K 2024-09
Philips EUR 8.38B 41M 2025-09
ResMed USD 846.35M 178.06M 2025-09
Steris USD 2.06B 10.4M 2025-09
Stryker USD 14.86B 1.74B 2025-12
Tandem Diabetes Care USD 449.28M 276K 2025-09
Teleflex USD 2.77B 774M 2025-09
X T L Biopharmaceuticals USD 138K 30K 2024-12
Zimmer Biomet Holdings USD 7.52B 593.5M 2025-12